Cephalosporin antibiotics, surprisingly, were found to selectively induce ferroptosis in NPC cells via HMOX1 activation, suggesting drug repurposing as a practical avenue for ferroptosis-based therapy [51]. The gene discussed is HMOX1; the disease is nasopharyngeal carcinoma.